Position in JNJ
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$302,090,711
+$8,105,168 QoQ
Shares Held
1,189,474
-1.1% QoQ
Ownership
0.049%
of shares outstanding
% of Portfolio
0.56%
of 13F equity value
Holder Rank
#155
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ROYAL LONDON ASSET MANAGEMENT LTD holds $4,029,879,846 across 10 Drug Manufacturers - General names. JNJ ranks #5 (7.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
10,161,026 | $1,926,733,750 | |
| 2 | LLY |
ELI LILLY & Co
|
645,864 | $774,668,722 | |
| 3 | MRK |
Merck & Co., Inc.
|
2,987,037 | $383,834,254 | |
| 4 | ABBV |
AbbVie Inc.
|
1,342,483 | $337,822,422 | |
| 5 | JNJ |
Johnson & Johnson
This page
|
1,189,474 | $302,090,711 | |
| 6 | AMGN |
Amgen Inc
|
280,510 | $101,578,281 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
551,867 | $69,722,876 | |
| 8 | PFE |
Pfizer Inc
|
2,819,076 | $67,883,350 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $302,090,711 | 1,189,474 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $293,985,543 | 1,202,690 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $236,185,826 | 1,141,270 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $205,332,995 | 1,107,394 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $145,130,677 | 950,119 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $268,654,829 | 1,619,964 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $235,269,551 | 1,626,812 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $263,638,397 | 1,626,795 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $233,192,579 | 1,595,461 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $268,375,504 | 1,696,539 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $253,855,947 | 1,619,599 | Shares | Sole | 2024-03-01 | |
| 2023-09-30 | $243,979,727 | 1,566,483 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $278,707,707 | 1,683,831 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $214,859,915 | 1,386,193 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $214,895,784 | 1,216,506 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $194,338,120 | 1,189,631 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $221,936,492 | 1,250,276 | Shares | Sole | 2022-09-06 | |
| 2022-03-31 | $222,810,188 | 1,257,181 | Shares | Sole | 2022-09-06 | |
| 2021-12-31 | $207,020,360 | 1,210,150 | Shares | Sole | 2022-10-18 | |
| 2021-09-30 | $205,166,047 | 1,270,378 | Shares | Sole | 2022-10-18 | |
| 2021-06-30 | $221,935,256 | 1,347,185 | Shares | Sole | 2022-10-18 | |
| 2021-03-31 | $236,619,461 | 1,439,729 | Shares | Sole | 2022-10-17 | |
| 2020-12-31 | $253,290,047 | 1,609,417 | Shares | Sole | 2021-01-29 | |
| 2020-09-30 | $239,791,785 | 1,610,638 | Shares | Sole | 2020-11-04 | |
| 2020-06-30 | $204,810,578 | 1,456,379 | Shares | Sole | 2020-07-31 | |
| 2020-03-31 | $198,729,744 | 1,515,517 | Shares | Sole | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||